Tag Archives: Angelman syndrome

New Angelman syndrome therapy proposed

lncRNA

from UT San Diego by Bradley J. Fikes Isis Pharma approach helps mouse models of genetic disease A potential therapy for Angelman syndrome, a baffling genetic disease that impairs intellectual development, has been proposed by scientists including researchers at Isis Pharmaceuticals. The treatment, tested in mice, activates a gene that restores some of the neurological activity reduced in Angelman syndrome, ...

Read More »